serw-MX  [xml]  
 
    
 DeCS Categories

C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.340 Extravasation of Diagnostic and Therapeutic Materials .
C23.550.340.500 Injection Site Reaction .
C25 Chemically-Induced Disorders .
C25.100 Drug-Related Side Effects and Adverse Reactions .
C25.100.781 Injection Site Reaction .
G02 Chemical Phenomena .
G02.111 Biochemical Phenomena .
G02.111.570 Molecular Structure .
G02.111.570.120 Binding Sites .
G02.111.570.120.704 Catalytic Domain .
G02.111.570.820 Molecular Conformation .
G02.111.570.820.709 Protein Conformation .
G02.111.570.820.709.275 Protein Structural Elements .
G02.111.570.820.709.275.750 Protein Domains .
G02.111.570.820.709.275.750.188 Catalytic Domain .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Catalytic Domain .
Active Sites .
Catalytic Cores .
Catalytic Domains .
Catalytic Regions .
Catalytic Sites .
Catalytic Subunits .
Core, Catalytic .
Cores, Catalytic .
Domain, Catalytic .
Domains, Catalytic .
Reactive Sites .
Region, Catalytic .
Regions, Catalytic .
Site, Active .
Site, Catalytic .
Site, Reactive .
Sites, Active .
Sites, Catalytic .
Sites, Reactive .
Subunit, Catalytic .
Subunits, Catalytic .
Active Site .
Catalytic Core .
Catalytic Region .
Catalytic Site .
Catalytic Subunit .
Reactive Site .
The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. .
1.00
824355
 
Injection Site Reaction .
Infusion Site Adverse Event .
Infusion Site Adverse Reaction .
Infusion Site Reaction .
Injection Site Adverse Event .
Injection Site Event .
Infusion Site Reactions .
Injection Site Events .
Injection Site Reactions .
Adverse reactions that occur initially at the site of injection or infusion. Milder type is confined to a local allergic flare reaction. A more severe reaction is caused by extravasation of VESICANTS from the blood vessel at the site of injection and can cause damage to the surrounding tissue. In tumor flare reaction symptoms involve well beyond the injection site such as an increase in the tumor size and tumor markers levels, bone pain, and HYPERCALCEMIA. .
0.71
40